Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC940128426;28427;28428 chr2:178710896;178710895;178710894chr2:179575623;179575622;179575621
N2AB908427475;27476;27477 chr2:178710896;178710895;178710894chr2:179575623;179575622;179575621
N2A815724694;24695;24696 chr2:178710896;178710895;178710894chr2:179575623;179575622;179575621
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATC
  • RefSeq wild type template codon: TAG
  • Domain: Ig-80
  • Domain position: 5
  • Structural Position: 5
  • Q(SASA): 0.418
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/F None None 0.772 None 0.281 0.311 0.463586170655 gnomAD-4.0.0 1.59235E-06 None None None None I None 0 0 None 0 0 None 0 2.41546E-04 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.2948 likely_benign 0.3077 benign -1.271 Destabilizing 0.103 N 0.268 neutral None None None None I
I/C 0.672 likely_pathogenic 0.668 pathogenic -0.442 Destabilizing 0.991 D 0.311 neutral None None None None I
I/D 0.5124 ambiguous 0.5263 ambiguous -0.967 Destabilizing 0.561 D 0.346 neutral None None None None I
I/E 0.3552 ambiguous 0.3498 ambiguous -1.035 Destabilizing 0.209 N 0.301 neutral None None None None I
I/F 0.1588 likely_benign 0.1644 benign -1.1 Destabilizing 0.772 D 0.281 neutral None None None None I
I/G 0.541 ambiguous 0.567 pathogenic -1.518 Destabilizing 0.561 D 0.327 neutral None None None None I
I/H 0.3263 likely_benign 0.3443 ambiguous -0.808 Destabilizing 0.901 D 0.323 neutral None None None None I
I/K 0.1792 likely_benign 0.18 benign -0.76 Destabilizing 0.017 N 0.239 neutral None None None None I
I/L 0.1227 likely_benign 0.1273 benign -0.697 Destabilizing 0.08 N 0.142 neutral None None None None I
I/M 0.1078 likely_benign 0.1124 benign -0.331 Destabilizing 0.873 D 0.288 neutral None None None None I
I/N 0.1713 likely_benign 0.1845 benign -0.387 Destabilizing 0.491 N 0.355 neutral None None None None I
I/P 0.8245 likely_pathogenic 0.8089 pathogenic -0.856 Destabilizing 0.722 D 0.368 neutral None None None None I
I/Q 0.2555 likely_benign 0.2664 benign -0.668 Destabilizing 0.047 N 0.273 neutral None None None None I
I/R 0.1424 likely_benign 0.1455 benign -0.086 Destabilizing 0.004 N 0.243 neutral None None None None I
I/S 0.2103 likely_benign 0.2201 benign -0.856 Destabilizing 0.166 N 0.275 neutral None None None None I
I/T 0.1883 likely_benign 0.1825 benign -0.823 Destabilizing 0.005 N 0.114 neutral None None None None I
I/V 0.094 likely_benign 0.0893 benign -0.856 Destabilizing 0.001 N 0.132 neutral None None None None I
I/W 0.7281 likely_pathogenic 0.7409 pathogenic -1.141 Destabilizing 0.991 D 0.321 neutral None None None None I
I/Y 0.3697 ambiguous 0.3851 ambiguous -0.929 Destabilizing 0.901 D 0.365 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.